These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 8133793

  • 1. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women.
    Adami S, Rossini M, Zamberlan N, Bertoldo F, Dorizzi R, Lo Cascio V.
    Maturitas; 1993 Nov; 17(3):191-6. PubMed ID: 8133793
    [Abstract] [Full Text] [Related]

  • 2. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
    Sendag F, Karadadas N, Ozsener S, Bilgin O.
    Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI, Crook D, Marsh MS, Ellerington MC, Whitehead MI, Stevenson JC.
    Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA, Farias ML, Andrade AT.
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
    Vigna GB, Donegà P, Zanca R, Barban A, Passaro A, Pansini F, Bonaccorsi G, Mollica G, Fellin R.
    Metabolism; 2002 Nov; 51(11):1463-70. PubMed ID: 12404199
    [Abstract] [Full Text] [Related]

  • 9. Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women.
    Rabbani LE, Seminario NA, Sciacca RR, Chen HJ, Giardina EG.
    J Am Coll Cardiol; 2002 Dec 04; 40(11):1991-9. PubMed ID: 12475460
    [Abstract] [Full Text] [Related]

  • 10. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H.
    Thromb Haemost; 2001 Apr 04; 85(4):619-25. PubMed ID: 11341495
    [Abstract] [Full Text] [Related]

  • 11. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
    Gevers Leuven JA, van der Mooren MJ, Buytenhek R.
    Fertil Steril; 1995 Sep 04; 64(3):525-31. PubMed ID: 7641905
    [Abstract] [Full Text] [Related]

  • 12. Substitution of transdermal estradiol during oral estrogen-progestin therapy in postmenopausal women: effects on hypertriglyceridemia.
    Sanada M, Tsuda M, Kodama I, Sakashita T, Nakagawa H, Ohama K.
    Menopause; 2004 Sep 04; 11(3):331-6. PubMed ID: 15167313
    [Abstract] [Full Text] [Related]

  • 13. Comparative effects of estrogens plus androgens and tibolone on bone, lipid pattern and sexuality in postmenopausal women.
    Castelo-Branco C, Vicente JJ, Figueras F, Sanjuan A, Martínez de Osaba MJ, Casals E, Pons F, Balasch J, Vanrell JA.
    Maturitas; 2000 Feb 15; 34(2):161-8. PubMed ID: 10714911
    [Abstract] [Full Text] [Related]

  • 14. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
    Lemay A, Dodin S, Cédrin I, T-Lemay L.
    Clin Endocrinol (Oxf); 1995 Apr 15; 42(4):341-51. PubMed ID: 7750187
    [Abstract] [Full Text] [Related]

  • 15. Hormone replacement therapy and lipid-lipoprotein concentrations.
    Gökmen O, Yapar Eyi EG.
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul 15; 85(1):31-41. PubMed ID: 10428319
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
    Perrone G, Stefanutti C, Galoppi P, Anelli G, Capri O, Lucani G, Vivenzio A, Mazzarella B, Zichella L.
    Int J Fertil Menopausal Stud; 1996 Jul 15; 41(6):509-15. PubMed ID: 9010744
    [Abstract] [Full Text] [Related]

  • 18. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 Jul 15; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 19. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
    Bhathena RK, Anklesaria BS, Ganatra AM, Pinto R.
    Br J Clin Pharmacol; 1998 Feb 15; 45(2):170-2. PubMed ID: 9491833
    [Abstract] [Full Text] [Related]

  • 20. Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study.
    Hänggi W, Lippuner K, Riesen W, Jaeger P, Birkhäuser MH.
    Br J Obstet Gynaecol; 1997 Jun 15; 104(6):708-17. PubMed ID: 9197875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.